Citations

Clear

5212 citation(s) found for "Wang, Li-Ju".

Ribonuclease recruitment using a small molecule reduced c9ALS/FTD r(G 4 C 2 ) repeat expansion in vitro and in vivo ALS models
Bush, Jessica A. , Aikawa, Haruo , Fuerst, Rita, Li, Yue , Ursu, Andrei , Meyer, Samantha M. , Benhamou, Raphael I. , Chen, Jonathan L. , Khan, Tanya , Wagner-Griffin, Sarah , Meter, Montina J. Van , Tong, Yuquan , Olafson, Hailey, McKee, Kendra , Childs‐Disney, Jessica L. , Zhang, Yong‐Jie , Wang, Eric T. , Wang, Kye Won , Petrucelli, Leonard , Van Meter, Montina J , McKee, Kendra K , Gendron, Tania F , Zhang, Yong-Jie , Coyne, Alyssa N , Wang, Eric T , Wang, Kye Won , Petrucelli, Leonard , Rothstein, Jeffrey D , Disney, Matthew D , Benhamou, Raphael I , Aikawa, Haruo , Gendron, Tania F. , Coyne, Alyssa N. , Yildirim, Ilyas , Rothstein, Jeffrey D. , Disney, Matthew D.

Mayo Clinic

Science Translational Medicine | October 27, 2021 | Volume: 13 | Issue: 617 | Pages: No page available

10.1126/scitranslmed.abd5991 | PMID 34705518 Get It

Small-molecule recruitment of an endogenous nuclease rescues pathologies associated with c9ALS/FTD in vivo by targeting an RNA repeat expansion.
Humoral and cellular immune responses to recombinant herpes zoster vaccine in patients with chronic lymphocytic leukemia and monoclonal B cell lymphocytosis
Muchtar, Eli , Koehler, Amber B. , Johnson, Michael , Rabe, Kari G. , Ding, Wei , Call, Timothy G. , Leis, José F., Kenderian, Saad S. , Hayman, Suzanne R. , Wang, Yucai , Hampel, Paul J. , Holets, Matthew, Darby, Heather C., Miao, Congrong, Canniff, Jennifer, Whitaker, Jennifer A. , Levin, Myron J. , Schmid, D. Scott , Kennedy, Richard B. , Weinberg, Adriana , Holets, Matthew A, Parikh, Sameer A , Chaffee, Kari G. , Kenderian, Saad Sirop , Ding, Wei , Muchtar, E , Koehler, Amber B , Wang, Yucai , Kennedy, Richard , Slager, Susan L. , Kay, Neil E. , Parikh, Sameer A.

Mayo Clinic

American Journal of Hematology | October 26, 2021 | Volume: 97 | Issue: 1 | Pages: 90-98

10.1002/ajh.26388 | PMID 34699616 Get It

AbstractMonoclonal B‐cell lymphocytosis (MBL) and chronic lymphocytic leukemia (CLL) are clonal B‐cell disorders associated with an increased risk of infections and impaired vaccination responses. We investigated the immunogenicity of recombinant zoster vaccine (RZV) in these patients. Individuals with MBL/untreated CLL and Bruton tyrosine kinase inhibitor (BTKi)‐treated CLL patients were given two doses of RZV separated by 2 months. Responses assessed at 3 and 12 months from the first dose of RZV by an anti‐glycoprotein E ELISA antibody assay and by dual‐color Interferon‐γ and Interleukin‐2FLUOROSPOT assays were compared to historic controls matched by age and sex. About 62 patients (37 MBL/untreated CLL and 25 BTKi‐treated CLL) were enrolled with a median age of 68 years at vaccination. An antibody response at 3 months was seen in 45% of participants, which was significantly lower compared to historic controls (63%, p = .03). The antibody response did not significantly differ between MBL/untreated CLL and BTKi‐treated CLL (51% vs. 36%, respectively, p = .23). The CD4+ T‐cell response to vaccination was significantly lower in study participants compared to controls (54% vs. 96%, p < .001), mainly due to lower responses among BTKi‐treated patients compared to untreated MBL/CLL (32% vs. 73%, p = .008). Overall, only 29% of participants achieved combined antibody and cellular responses to RZV. Among participants with response assessment at 12 months (n = 47), 24% had antibody titers below the response threshold. Hypogammaglobulinemia and BTKi therapy were associated with reduced T‐cell responses in a univariate analysis. Strategies to improve vaccine response to RZV among MBL/CLL patients are needed.
Systematic Review and Meta-analysis of Acute Treatments for Episodic Migraine in Adults—Reply
Wang, Zhen , VanderPluym, Juliana H. , Murad, M. Hassan , Murad, Mohammad Hassan

Mayo Clinic

JAMA | October 26, 2021 | Volume: 326 | Issue: 16 | Pages: 1637

10.1001/jama.2021.14069 | PMID 34698787 Get It

Molecular markers of risk of subsequent invasive breast cancer in women with ductal carcinoma in situ: protocol for a population-based cohort study
Rohan, Thomas E. , Ginsberg, Mindy , Wang, Yihong , Couch, Fergus J. , Feigelson, Heather Spencer , Greenlee, Robert T. , Honda, Stacey , Stark, Azadeh , Chitale, Dhananjay , Wang, Tao , Xue, Xiaonan , Oktay, Maja H. , Loudig, Olivier , Feigelson, Heather S , Sparano, Joseph A , Loudig, Olivier , Couch, Fergus J. , Wang, Yihong , Chitale, Dhananjay A , Sparano, Joseph A.

Mayo Clinic

BMJ Open | October 26, 2021 | Volume: 11 | Issue: 10 | Pages: e053397

10.1136/bmjopen-2021-053397 | PMID 34702732 Get It

Introduction Ductal carcinoma in situ (DCIS) of the breast is a non-obligate precursor of invasive breast cancer (IBC). Many DCIS patients are either undertreated or overtreated. The overarching goal of the study described here is to facilitate detection of patients with DCIS at risk of IBC development. Here, we propose to use risk factor data and formalin-fixed paraffin-embedded (FFPE) DCIS tissue from a large, ethnically diverse, population-based cohort of 8175 women with a first diagnosis of DCIS and followed for subsequent IBC to: identify/validate miRNA expression changes in DCIS tissue associated with risk of subsequent IBC; evaluate ipsilateral IBC risk in association with two previously identified marker sets (triple immunopositivity for p16, COX-2, Ki67; Oncotype DX Breast DCIS score); examine the association of risk factor data with IBC risk. Methods and analysis We are conducting a series of case–control studies nested within the cohort. Cases are women with DCIS who developed subsequent IBC; controls (2/case) are matched to cases on calendar year of and age at DCIS diagnosis. We project 485 cases/970 controls in the aim focused on risk factors. We estimate obtaining FFPE tissue for 320 cases/640 controls for the aim focused on miRNAs; of these, 173 cases/346 controls will be included in the aim focused on p16, COX-2 and Ki67 immunopositivity, and of the latter, 156 case–control pairs will be included in the aim focused on the Oncotype DX Breast DCIS score®. Multivariate conditional logistic regression will be used for statistical analyses. Ethics and dissemination Ethics approval was obtained from the Institutional Review Boards of Albert Einstein College of Medicine (IRB 2014-3611), Kaiser Permanente Colorado, Kaiser Permanente Hawaii, Henry Ford Health System, Mayo Clinic, Marshfield Clinic Research Institute and Hackensack Meridian Health, and from Lifespan Research Protection Office. The study results will be presented at meetings and published in peer-reviewed journals.
DNA Methylation Profiles of Ovarian Clear Cell Carcinoma
Cunningham, Julie M. , Winham, Stacey J. , Wang, Chen , Weiglt, Britta, Fu, Zhuxuan, Armasu, Sebastian M., McCauley, Bryan M., Brand, Alison H., Chiew, Yoke-Eng , Elishaev, Esther, Gourley, Charlie , Kennedy, Catherine J. , Laslavic, Angela, Lester, Jenny, Piskorz, Anna, Sekowska, Magdalena, Brenton, James D. , DeFazio, Anna , Drapkin, Ronny , Huntsman, David G., Köbel, Martin , Konner, Jason, Lawrenson, Kate , Papaemmanuil, Elli, Bolton, Kelly L., Goode, Ellen L., Brand, Alison H. , Fu, Zhuxuan , Churchman, Michael , Fazio, Anna de , Drapkin, Ronny , Elias, Kevin M , Karlan, Beth Y , Köbel, Martin , Lawrenson, Kate , Modugno, Francesmary , Winham, Stacey J , Brenton, James D , Wang, Chen , Kennedy, Catherine J , Fu, Zhuxuan , Brand, Alison H , Chiew, Yoke-Eng , Cunningham, Julie M , Weiglt, Britta, Fu, Zhuxuan, Armasu, Sebastian M., McCauley, Bryan M., Brand, Alison H., Elishaev, Esther, Gourley, Charlie , Laslavic, Angela, Lester, Jenny, Piskorz, Anna, Sekowska, Magdalena, Huntsman, David G., Konner, Jason, Papaemmanuil, Elli, Bolton, Kelly L., Goode, Ellen L.

Mayo Clinic

Cancer Epidemiology, Biomarkers & Prevention | October 25, 2021 | Volume: 31 | Issue: 1 | Pages: 132-141

10.1158/1055-9965.epi-21-0677 | PMID 34697060 Get It

Abstract Background: Ovarian clear cell carcinoma (OCCC) is a rare ovarian cancer histotype that tends to be resistant to standard platinum-based chemotherapeutics. We sought to better understand the role of DNA methylation in clinical and biological subclassification of OCCC. Methods: We interrogated genome-wide methylation using DNA from fresh frozen tumors from 271 cases, applied nonsmooth nonnegative matrix factorization (nsNMF) clustering, and evaluated clinical associations and biological pathways. Results: Two approximately equally sized clusters that associated with several clinical features were identified. Compared with Cluster 2 (N = 137), Cluster 1 cases (N = 134) presented at a more advanced stage, were less likely to be of Asian ancestry, and tended to have poorer outcomes including macroscopic residual disease following primary debulking surgery (P &lt; 0.10). Subset analyses of targeted tumor sequencing and IHC data revealed that Cluster 1 tumors showed TP53 mutation and abnormal p53 expression, and Cluster 2 tumors showed aneuploidy and ARID1A/PIK3CA mutation (P &lt; 0.05). Cluster-defining CpGs included 1,388 CpGs residing within 200 bp of the transcription start sites of 977 genes; 38% of these genes (N = 369 genes) were differentially expressed across cluster in transcriptomic subset analysis (P &lt; 10−4). Differentially expressed genes were enriched for six immune-related pathways, including IFNα and IFNγ responses (P &lt; 10−6). Conclusions: DNA methylation clusters in OCCC correlate with disease features and gene expression patterns among immune pathways. Impact: This work serves as a foundation for integrative analyses that better understand the complex biology of OCCC in an effort to improve potential for development of targeted therapeutics.
S1421 Safety and Efficacy of Long-Term Treatment With Lirentelimab, A Monoclonal Antibody Against Siglec-8, in Patients With Eosinophilic Gastritis and/or Duodenitis
Chehade, Mirna , Leung, John , Hazan, Sabine , Vaezi, Michael F. , Bledsoe, Adam C. , Durrani, Sandy , Shaw, Camilla, Chang, Alan K. , Singh, Bhupinder , Kamboj, Amol P. , Rasmussen, Henrik , Hirano, Ikuo , Murray, Joseph A. , Peterson, Kathryn A. , Falk, Gary W. , Gonsalves, Nirmala , Genta, Robert M. , Khoury, Paneez , Klion, Amy D. , Wang, Chao , Chang, Alan, Rothenberg, Marc E. , Dellon, Evan S.

Mayo Clinic

American Journal of Gastroenterology | October 24, 2021 | Volume: 116 | Issue: 1 | Pages: S651-S652

10.14309/01.ajg.0000779216.88552.60 Get It

S3060 Adult Onset Complicated Meckel's Diverticulum
Heinrich, Matthew A. , Heinrich, Matthew, Wang, Xiao‐Jing

Mayo Clinic

American Journal of Gastroenterology | October 24, 2021 | Volume: 116 | Issue: 1 | Pages: S1263-S1263

10.14309/01.ajg.0000785772.31527.92 Get It

S1036 High-Definition Probe-Based Confocal Laser Endomicroscopy for the Detection of Neoplasia in Patients With Barrett's Esophagus: A Systematic Review and Meta-Analysis
Chahine, Anastasia , DeMeester, Steven R. , Wang, Kenneth T. , Ayub, Kamran, Buckley, P., Leggett, Philip, Severson, Paul , Samarasena, Jason , Buckley, Paul

Mayo Clinic

American Journal of Gastroenterology | October 24, 2021 | Volume: 116 | Issue: 1 | Pages: S491-S491

10.14309/01.ajg.0000777676.92475.42 Get It

S958 Pharmacogene CYP1A2*1F Polymorphism Lowers Anti-TNF (infliximab) Response in Inflammatory Bowel Disease Patients
Wang, Ming‐Hsi , Timmons, Lawrence J., Koop, Andree , Tremaine, William J.

Mayo Clinic

American Journal of Gastroenterology | October 24, 2021 | Volume: 116 | Issue: 1 | Pages: S458-S458

10.14309/01.ajg.0000777364.76967.26 Get It